Cover%20Photo6_edited_edited_edited.jpg

CUPROUS PHARMACEUTICALS

Providing partners with technologies to create best-in-class nanomedicines

 

INNOVATE & COLLABORATE

THIS IS WHAT WE DO

IMG_4173.jpg
Meeting

NANOTECHNOLOGIES

At Cuprous, we specialize in developing technologies that result in the creation of novel, best-in-class small molecules by overcoming developmental barriers and improving safety and therapeutic activity.

PARTNERSHIPS

Cuprous offers its enabling technologies to its partners to create best-in-class nanomedicines to address unmet medical needs.

 

NEWSROOM

 
unnamed (2).jpg

DEVELOPMENT AND CHARACTERIZATION OF A NOVEL FLAVOPIRIDOL FORMULATION FOR TREATMENT OF ACUTE MYELOID LEUKEMIA

March 30, 2021

Cuprous' Metaplex Technology has been used to develop a Flavopiridol formulation that provides a 30-fold increase in plasma AUC and an associated increase in therapeutic activity in models of AML.

THE CUPROUS TEAM

Tom Redelmeier.png

Founder, CEO & President

Mike Abrams (linkedin).jpg

Vice President, Research

Marcel Bally_cropped.png

Founder, Chief Scientific Officer

AACR PLOS ii 055 (1).jpg

Founder, Director of Operations

Ghania Chikh.jpg

GHANIA CHIKH, PHD

Scientific Advisor

 

GET IN TOUCH

  • LinkedIn

Thanks for submitting!